The NOSTRADAMUS Study: Microvascular Dysfunction in Sepsis
Share this article Share this article ALPINE, Utah, April 19, 2021 /PRNewswire/ -- A new study using GlycoCheck, and co-authored by GlycoCheck Chief Science Offer, Dr. Hans Vink, reports new findings of research on patients with sepsis. The study, titled "Identification of novel sublingual parameters to analyze and diagnose microvascular dysfunction in sepsis: the NOSTRADAMUS study" was published in Critical Care. Critical Care is a high-quality, peer-reviewed, international clinical medica...
United States Gary Hennerberg Hans Vink Robert Long Microvascular Health Solutions Glycocheck Chief Science Offer
Source: prnewswire.com